Wednesday, September 25, 2013

Phenylketonuria

Phenylketonuria (PKU) is an autosomal recessive metabolic genetic disorder characterized by a mutation in the gene for the hepatic enzyme phenylalanine hydroxylase (PAH), rendering it nonfunctional.:541 This enzyme is necessary to metabolize the amino acid phenylalanine (Phe) to the amino acidic Tyr. When PAH activity is reduced, phenylalanine accumulates and is converted into phenylpyruvate (also understood as phenylketone), which can be detected in the urine.

Untreated PKU can lead to mental retardation, seizures, and other serious medicinal problems. The mainstream treat for classic PKU patients is a strict PHE-restricted diet eke out by a medical formula containing amino acids and other nutrients. In the United States, the current recommendation is that the PKU feed should be allege for life. Patients who are diagnosed seasonably and maintain a nice diet can have a perpendicular life hobble with normal intellectual development. However, new research suggests that neurocognitive, psychosocial, quality of biography, growth, nutriment, dice pathology are slightly suboptimal if victuals is not supplemented with amino acids.

Phenylketonuria was discovered by the Norwegian physician Ivar Asbjørn Følling in 1934 when he consideration hyperphenylalaninemia (HPA) was associated with mental hindrance. In Norway, this indisposition is assumed as Følling's disorder, called after its explorer. Følling was one of the first physicians to apply detailed chemical analysis to the ponder of ailing. His solicitous analysis of the urine of two beloved siblings led him to supplication many physicians nigh Oslo to experience the urine of other beloved patients. This led to the discovery of the same substance he had found in eight other patients. He conducted tests and found reactions that gave rise to benzaldehyde and benzoic acidic, which led him to conclude that the compound contained a benzene ring. Further testing guide the liquefaction stage to be the same as phenylpyruvic acid, which indicated that the substance was in the urine. His solicitous science inhaled many to continue like meticulous and faithful investigation with other disorders. It was recently suggested that PKU may simulate amyloid diseases, such as Alzheimer's illness and Parkinson's disease, due to the formation of toxic amyloid-like assemblies of phenylalanine.

PKU is usually inclosed in the newborn screening panel of most countries, with varied detection techniques. Most babies in developed countries are screened for PKU soon after birth. Screening for PKU is done with bacterial prohibition assay (Guthrie test), immunoassays using fluorometric or photometric detection, or amino acid measurement using tandem bicycle mass spectrometry (MS/MS). Measurements done using MS/MS determine the concentration of Phe and the ratio of Phe to Tyr, both of which will be elevated in PKU.

Untreated goats are exact at origin, but disappoint to reach rathe developmental milestones, disentangle microcephaly, and prove progressive harm of cerebral activity. Hyperactivity, EEG abnormalities, and seizures, and censorious learning disabilities are major clinical problems later in spirit. A "musty or mousy" odor of skin, hair, sweat and urinate (due to phenylacetate aggregate), as well as a tendency towards hypopigmentation and eczema, are also observed.

PKU is understood to be an autosomal retrogressive hereditary disorder. This means both parents must have at least one mutated allele of the PAH gene. The bairn must inherit both mutated alleles, one from each parent. Therefore, if both cause are carriers for PKU, there is a 25% opportunity their child with develop the indisposition, a 50% accident their lass will be a messenger, and a 25% chance their lad will neither project nor be a carrier for the disease.

Phenylketonuria can live in mice, which have been extensively habit in experiments into finding an effective usage for it. The macaque sagoin's genome was latterly sequenced, and the gene encoding phenylalanine hydroxylase was found to have the same sequence that, in humans, would be considered the PKU mutation.

A rarer form of hyperphenylalaninemia occurs when PAH is normal, but there is a injure in the biosynthesis or recycling of the cofactor tetrahydrobiopterin (BH4) by the magnanimous. This cofactor is needment for proper energy of the enzyme . The coenzyme (called biopterin) can be supplemented as handling. Those who suffer from PKU must be supplemented with Tyr to recital for phenylalanine hydroxylase imperfection in converting phenylalanine to tyrosine enough. Dihydrobiopterin reductase activity is to replenish quinonoid-dihydrobiopterin back into its tetrahydrobiopterin beauty, which is an momentous cofactor in many metabolic reactions in amino acid metabolism. Those with this failure may furnish sufficient clear of Phe hydroxylase, but since tetrahydrobiopterin is a cofactor for Phe hydroxylase quickness, scant dihydrobiopterin reductase renders any Phe hydroxylase enzyme produced helpless to use phenylalanine to manufacture tyrosine. Tetrahydrobiopterin is also a cofactor in the work of L-DOPA from tyrosine and 5-Hydroxy-L-Tryptophan from tryptophan, which must also be supplemented as treatment in accession to the supplements for canonical PKU.

The enzyme Phe hydroxylase normally converts the amino acid phenylalanine into the amino rough Tyr. If this revulsion does not take place, phenylalanine accumulates and tyrosine is poor. Excessive Phe can be metabolized into phenylketones through the minor route, a transaminase pathway with glutamate. Metabolites intercept phenylacetate, phenylpyruvate and phenethylamine. Elevated levels of phenylalanine in the blood and detection of phenylketones in the water is diagnostic, however most patients are diagnosed via newborn screening.

Phenylalanine is a large, neutral amino acrimonious (LNAA). LNAAs race for carriage across the blood–fancy barrier (BBB) via the huge colorless amino tart shipper (LNAAT). If phenylalanine is in excess in the blood, it will saturate the carrier. Excessive levels of phenylalanine tend to decrease the levels of other LNAAs in the genius. However, as these amino acids are necessary for protein and neurotransmitter composition, Phe buildup block the deduction of the brain, causing psychical hindrance.

If PKU is diagnosed soon enough, an beloved newborn can wax up with analogical fancy educement, but only by managing and govern Phe flat through food, or a combination of diet and medication. Optimal heal frequent (or "target ramble") are between 120 and 360 µmol/L, and aimed to be fulfill during at least the first 10 yonks. When Phe cannot be metabolized by the substance, extraordinarily high levels collect in the destruction and are poisonous to the genius. When left untreated, complications of PKU include severe emotional retardation, imagination function abnormalities, microcephaly, mood indisposition, irregular motor cosine, and behavioral problems such as attention deficit hyperactivity disease.

All PKU patients must cling to a special diet low in Phe for optimal brain eduction. "Diet for life" has become the colors recommended by most experts. The diet need severely restricting or give the walking papers to foods high in Phe, such as meat, chick, go fish, eggs, nuts, cheese, legumes, milk and other dairy products. Starchy foods, such as potatoes, bread, paste, and grain, must be monitored. Infants may still be breastfed to foresee all of the benefits of breastmilk, but the quantity must also be monitored and supplementation for missing nutrients will be required. The sweetener E951, present in many fare foods and delicate hear, must also be avoided, as aspartame contains phenylalanine.

Supplementary infant formulas are used in these patients to provide the amino acids and other needment nutrients that would otherwise be lacking in a flame-phenylalanine diet. As the child grows up these can be replaced with tablet, formulas, and expressly formulated foods. (Since Phe is privy for the composition of many proteins, it is ask for appropriate vegetation, but levels must be strictly superintendence in PKU patients.) In addition, tyrosine, which is ordinarily derived from phenylalanine, must be supplemented.

The unwritten regulation of sapropterin (or BH4) (a cofactor for the oxygenation of phenylalanine) can reduce blood open of this amino tart in undoubted patients. The corporation BioMarin Pharmaceutical has produced a tablet preparation of the pay sapropterin dihydrochloride (Kuvan), which is a form of tetrahydrobiopterin. Kuvan is the first drug that can serve BH4-responsive PKU patients (defined among clinicians as near 1/2 of the PKU population) lower Phe levels to recommended sift. Working secretly with a dietitian, some PKU patients who rejoin to Kuvan may also be able to advance the amount of characteristic protein they can eat. After statewide clinical essay, Kuvan has been approved by the FDA for utility in PKU therapy. Some researchers and clinicians working with PKU are maintenance Kuvan a wicked and effective addition to dietary management and beneficial to patients with PKU.

Several other therapies are currently under investigation, including gene therapeutics, copious neutral amino acids, and enzyme novation therapeutics with phenylalanine ammonia lyase (PAL). In the spent, PKU-affected relations were allowed to go off diet after near eight, then 18 years of age. Today, most physicians commend PKU patients must contrive their Phe direct throughout life.

For women with phenylketonuria, it is idiopathic for the health of their people to affirm flame Phe even before and during gravidness. Though the developing fetus may only be a carrier of the PKU gene, the intrauterine surrounding can have very proud open of phenylalanine, which can cross the placenta. The child may lay open constitutional heart disease, growth retardation, microcephaly and inner retardation as a issue. PKU-affected women themselves are not at risk of else complications during pregnancy.

In most countries, ladies with PKU who invoke to have children are advised to lower their consanguinity Phe even (typically to between 2 and 6 mg/dL) before they become weighty, and carefully control their levels throughout the pregnancy. This is achieved by performing normal blood criterion and adhering very precisely to a diet, in general oversee on a day-to-day basis by a specialist metabolic dietitian. In many cause, as the fetus' liver begins to unfold and produce PAH frequently, the mother's consanguinity Phe straightforward will drop, need an increased intake to endure within the wicked range of 2–6 mg/dL. The mother's daily Phe intake may double or even treble by the termination of the pregnancy, as a result. When maternal blood Phe straightforward fall below 2 mg/dL, anecdotal story indicate that the mamma may support unwilling operation, including headaches, nausea, filament loss, and indefinite malaise. When low phenylalanine levels are affirm for the duration of pregnancy, there are no elevated levels of peril of extraction defects comparison with a doll innate to a non-PKU mother. Babies with PKU may drink breast milk, while also apprehension their singular metabolic formula. Some research has indicated an exclusive session of soul milk for PKU fondle may modify the effects of the want, though during breastfeeding the mother must maintain a exact diet to keep her Phe horizontal moo. More research is needful. US savant announced in June 2010 that they would be conducting a thorough scrutation on the mutation of genes in the human genome. Their top priority is PKU, as it has become increasingly common, and sufferers often convey children who will be carriers of the retrogressive gene, and may themselves exist past the epoch of sixty.

The indicate falling of PKU modify fare in dissimilar human populations. United States Caucasians are affected at a rate of 1 in 10,000. Turkey has the highest documented rate in the world, with 1 in 2,600 descent, while countries such as Finland and Japan have exceedingly light scold with fewer than one case of PKU in 100,000 lineage. A 1987 study from Slovakia recite a Roma population with an extremely high incidence of PKU (one case in 40 consanguineous) due to broad inbreeding.

Amino acids are the building stuff for protein, but too much phenylalanine can cause a kind of health problems. People with PKU (PKU) — fondle, kids and adults — need to succeed a diet that limits Phe, which is found mostly in foods that contain protein.

Reference

Phenylketonuria. (2013). Retrieved on September 26, 2013, from http://en.wikipedia.org/wiki/Phenylketonuria.
Phenylketonuria. (2013). Retrieved on September 26, 2013, from http://ghr.nlm.nih.gov/condition/phenylketonuria.
Phenylketonuria. Retrieved on September 26, 2013, from http://www.mayoclinic.com/health/phenylketonuria/DS00514.

phenylketonuria

English name : phenylketonuria
Alias: phenylketonuria ; phenylalanine hydroxylase deficiency ; phenylalanine hydroxylase deficiency ; phenylalanine hydroxylase deficiency
Overview :
Urine that is phenylketonuria phenylketonuria (phenylketonuria, PKU) is due to phenylalanine metabolic pathway , the enzyme defect caused by the more common autosomal recessive genetic disease, the earliest in 1934 found that patients due Foiling urine contains a lot of phenylketonuria named. 1947 Jervis phenylalanine load the patient experiments reveal the biochemical basis of PKU incidence of liver phenylalanine metabolism. In 1953, the German Bickel first reported side with a low phenylalanine milk PKU patient treatment to be successful . 1963 G. .. [ Detail ... ]
Etiology:
The disease is an autosomal recessive genetic disease , the Department of phenylalanine metabolic pathway enzyme deficiencies.
Clinical manifestations:
Most children appear normal at birth , neonatal period no specific clinical symptoms, some patients may be feeding difficulties , vomiting , irritability and other non -specific symptoms . Untreated children 3 to 4 months after gradually showing intelligence, sports retardation, hair from black to yellow , white skin , body odor and urine with special mouse , often eczema. With age, children with mental retardation became increasingly obvious that about 60% of older children with severe mental retardation . 2 /3 of children with mild neurological signs , such as increased muscle tone, tendon hyperreflexia , microcephaly , severe cases may have cerebral palsy . About 1/4 of children with seizures ... [ Detail ... ]
Treatment:
1 PKU is the first principle of treatment can be controlled through diet therapy of inherited metabolic diseases . Inclusive of a certain amount of natural food phenylalanine, low-protein diet will lead to malnutrition, so use low- phenylalanine diet therapy , such as the production of China on the 2nd Shanghai or other similar products , the treatment principles are as follows :
( 1 ) Early Treatment: Once diagnosed , should be treated immediately . The younger the start of treatment , the better the prognosis , smart development close to normal . Late treatment have varying degrees of mental retardation . 3 to 5 years after treatment, may reduce seizures and behavioral abnormalities ... [ Detail ... ]
Prognosis:
Avoid relatives married. Marriage should be between a heterozygote . Conduct newborn screening for the early detection PKU sick children , early initiation of treatment to prevent the occurrence of mental retardation. For high-risk family , do prenatal diagnosis to decide whether to make selective abortion . There is a family history of the disease on the couple must use DNA analysis or detection methods such as amniotic fluid neopterin their fetuses for prenatal diagnosis.

Tuesday, August 27, 2013

PKU (Phenylketonuria, PKU) FAQ

Prenatal diagnosisQ * Will phenylketonuria at check-check it out when you can do?A * due to congenital anomalies are many reasons, there is not no family history of the disease for all congenital fetal anomaly detection, unless you already know someone in phenylketonuria patients and found mutations on the gene location, is it possible to provide for your baby prenatal check phenylketonuria. We recommend that you can be close to genetic counseling centers for further consultation.
 
Newborn ScreeningQ * as told by hospitals to report suspected suffering from phenylketonuria newborn screening is required again to re-examination. I ask you:1 to the current screening devices or whether the process will be errors or mistakes?(2) the domestic positive initial screening out the false positive probability is about how much?3 again after re-examination to determine the probability of positive or what percentage?4, such as whether poor neonatal liver can also cause metabolic initial inspection is positive?5 Because twenty-three days before breastfeeding posture, resulting in baby milk supply is very limited indeed absorbed (Unknown inspection required before breast-feeding full 48 hours), whether this will result in an initial inspection of the results of this generation?A * newborn screening for phenylketonuria positive cases may be due to liver dysfunction caused by a temporary increase in the concentration of phenylalanine, or because of congenital metabolic enzyme phenylalanine deficiency leads to high amphetamine acidosis (Hyperphenylalaninemia) and therefore need further referral. National Taiwan University Hospital, 93-94 years of experience, into the re-examination work (to be taken a second blood films) of every hundred, about 42 people identified as high amphetamine acidosis, as to enter the confirmation operation (subject to the hospital do confirm the diagnosis) of eight people, eight were identified as high amphetamine acidosis. We understand the concerns of parents, suggests that parents work with the re-examination, re-examination report on the results the first patient is appropriate.Q * I am a patient suspected positive phenylketonuria families, children born in March after screening three values ​​are 2.0 times, to the hospital after re-examination, in May back to hospital that blood is normal, but the urine for drug type. Will Since normal blood, which means that phenylketonuria insufficient concentration, why urine value will be high? Typical phenylketonuria do this count? Newborn blood screening that they represent what? Altogether in order to judge the urine like, why 2.0 or less normal blood, it is determined as abnormal?A * Since we do not see your child's urine test results, so no way of knowing the exact situation. In general, newborn screening is to look at the value of phenylalanine in the blood is increased, if the rising phenomenon, which means that phenylalanine metabolism pathway hinder it. But phenylalanine metabolic pathway obstruction causes, there may be metabolic enzyme phenylalanine itself wrong, or this enzyme cofactor manufacturing problems, also, or the child's liver enzymes metabolize the amino acids in the neonatal period not yet mature due. Urine test is usually producing coenzyme order to identify whether there is a problem in the differential diagnosis of which is an important examination. Fortunately, your child amphetamine acid is not high, may represent your child if coenzyme metabolic pathway is not very smooth, but for kids the body's metabolism of phenylalanine, pretty enough, but when in poor physical condition, such as illness cold time, will have to check whether there is a rising phenylalanine phenomenon. Recommend that you check again urine, and confirm the status of coenzyme metabolic pathways, if you have additional questions, please communicate with your physician for further discussion.
 
TreatmentQ * Will be judged if the newborn is typical PKU, whether it may be false positive? Do they need to re-examine? May heal you grow up? Do a liver transplant can cure? Way to cure the current classic PKU What?A * If the newborn screening found to have abnormal increase in phenylalanine will then notify the confirmation and differential diagnosis to receive specialist clinical assessment, and blood and urine tests and analysis related to the content of amino acids, and will then conducted a number of inspections to step into a distinction is typical (PAH deficiency) or drug type (BH4 deficiency) in patients with phenylketonuria. PKU is autosomal recessive congenital metabolic disorders, growth will not be healed, if recognized as patients receiving early dietary protein restriction therapy, can have good results. Current clinical liver transplantation as a treatment is not the way, if the examination and treatment of the doubt, and then discussed with the attending physician.
 
Disease CareQ * Can I ask, what factors will cause PKU disease in children speaking and walking road barriers, as well as lighter hair color and a musty causes it?A * You mentioned symptoms associated with PKU is associated with in vivo phenylalanine (phenylalanine; Phe) value is too high for, but if the amount of this amino acid in the body control is good, there will not be mentioned in your Symptoms produced, Thank you for your letter.Q * Will the current prognosis of PKU in Taiwan?A * PKU patients by the lack of an enzyme can be divided into PAH deficiency (treatment depends mainly on diet control), and BH4 deficiency (treatment comprising administering BH4, may need to be controlled with diet to achieve the desired concentration of phenylalanine in the blood). At present, due to the implementation of newborn screening, and PKU patients can get early diagnosis and treatment, so most of them can have good growth and development and academic performance.

Phenylketonuria, PKU

Phenylketonuria (PKU) is an autosomal recessive genetic disease, mainly due to the body phenylalanine (phenylalanine; Phe) hydroxylation (hydroxylation) into tyrosine (tyrosine; Tyr) machines impaired metabolic pathway caused congenital metabolic disorders . There are five different enzymes are known to be the cause of such a lack of metabolic machine failure; these include: phenylalanine hydroxylase enzyme (phenylalanine
hydroxylase; PAH), guanine nucleoside triphosphate cyclization hydrolase (Gtp cyclohydrolase I; GTPCHI), propanedione tetrahydro neopterin synthase (6-pyruvoyl tetrahydropterin synthase; PTPS), dihydrotestosterone pteridine reductase (dihydropteridine reductase; DHPR) and neopterin methanol amine dewatering enzyme (pterin-4 -carbinolamine dehydratase; PCD). Different according to their deficiency, have different clinical symptoms and diagnostic methods, the treatment method is not the same.
Because aspartame contains phenylalanine, so containing this sweetener (E950 and E951) drinks (example: Coca-Cola zero) are not suitable for patients with phenylketonuria drinking.
Patients with liver phenylalanine hydroxylase deficiency, making dietary phenylalanine can not be converted to tyrosine, phenylalanine, resulting in accumulation within the brain, the role of transaminase into phenylketonuria, thus affecting the patient brain development, causing mental retardation and epilepsy, and to patients with skin bleaching, hair yellow, smell a rat urine and other symptoms.


Phenylketonuria Diagram


Phenylketonuria,PKU

Etiology:High amphetamine acidosis (Hyperphenylalaninemia), also known as PKU (phenylketonuria), is an autosomal recessive genetic disease, mainly due to the body phenylalanine (phenylalanine; Phe) hydroxylation (hydroxylation) into tyrosine (tyrosine ; Tyr) metabolic pathways of local failure caused by congenital metabolic disorders. There are five different enzymes are known to be the cause of such a lack of metabolic barrier according to their lack of different machines, different clinical symptoms and diagnosis, the treatment methods are not the same.
Five different enzymesPhenylalanine hydroxylase enzyme Phenylalanine hydroxylase / PAH PAH deficiencyGuanine nucleoside triphosphate hydrolase cyclization Gtp cyclohydrolase I / GTPCHI BH4 deficiencyPropanedione tetrahydro neopterin synthesis enzyme 6-pyruvoyl tetrahydropterin synthase / PTPS BH4 deficiencyHydrochlorothiazide pteridine reductase dihydropteridine reductase / DHPR BH4 deficiencyNeopterin methanolamine dehydrated enzyme pterin-4-carbinolamine dehydratase / PCD BH4 deficiencyIncidence:Europe and the United States occur in approximately ten thousandth, eight hundred and seventy thousand domestic newborn screening results show that the incidence is about 1/34000.
Genetic model:Is an autosomal recessive genetic disease, the parents each with a mutated gene, but no clinical symptoms were due to be called with. Patients themselves must be the same time with two mutant genes (by the parents each get a mutated gene) before onset; as long as both parents are carriers, then each tire gender birth disease probability is 1/4 .
Clinical features:Patients because they can not metabolize food protein contains phenylalanine, resulting in the accumulation of phenylalanine in the blood, and thus the infant or child's brain and central nervous system, causing permanent damage, resulting in mental retardation. If diagnosed early, giving last a lifetime diet, can effectively prevent mental retardation issue. According to foreign reports in the literature of patients treated within one month, the average IQ of 95, one to two months before the treatment of the patients, with an average IQ of 85; rather late treated or untreated, their average IQ of 53-45 . The first enzyme phenylalanine hydroxylase (PAH) deficiency: The most common cause typical phenylketonuriaShow clinical symptoms of yellow hair, pale skin dryness and intelligent disability sequelae. PKU patients in Europe and America about 98 ~ 99% for this type of domestic PKU patients only about 70 to 80% of patients with this type.The second to the fifth cause lack of phenylalanine into tyrosine hydroxylase coenzyme necessary when methotrexate tetrahydro Health (tetrahydrobiopterin; BH4) deficiencyThe clinical symptoms in addition to some of the typical symptoms of phenylketonuria, there are strict kind of neurological symptoms (such as convulsions), growth retardation, easy to infection. China's PKU patients about 20% to 30% of the students neopterin tetrahydro-deficient, the special needs of the differential diagnosis in order to take proper treatment.
Diagnosis:Newborn screening filter paper blood spots were measured specimen phenylalanine levels, when the concentration is higher than 120 mM blood should further review, phenylalanine concentrations continue to rise if the phenomenon, which should be recognized and differential diagnosis. Also screening in the neonatal period such amino acid metabolism, the need to pay attention to whether the case has been getting enough protein (feeding more than 48 hours), in order to avoid the generation of false negatives.Positive cases may be due to liver dysfunction caused by a temporary increase in the concentration of phenylalanine, or because of congenital metabolic enzyme phenylalanine deficiency leads to high amphetamine acidosis (Hyperphenylalaninemia), thus further confirm the diagnosis. Confirm the diagnosis in addition to the clinical assessment of pediatric specialist outside laboratory confirmation method for the analysis of blood and urine related to the content of amino acids, and the need to tie in with other related analysis to confirm the diagnosis.Distinguish between patients with PAH deficiency or lack of BH4 methods include oral BH4 loading test (BH4 loading test), neopterin urine (urine pterin) analysis neurotransmitters cerebrospinal fluid (CSF neurotransmitter) analysis, quantification of erythrocyte DHPR activity. Oral BH4 loading test was monitored after oral BH4 concentration of phenylalanine in the blood is decreased, and if more than 30% decline, it means taking the case on BH4 responsive (responsive), may consider the use of oral BH4 treatment. However, this test need blood once every two hours, so be patient way to detect better.
Treatment:Without early treatment will result in severe mental retardation, so the damage to the brain disease is progressive in nature, and therefore more asymptomatic newborn babies, about 3 to 4 months or so symptoms will slowly appear. The sooner the better therapeutic effect, according to foreign reports in the literature that patients treated within a month, the average IQ of 95,1 ~ 2 months before treatment of patients with an average IQ of 85; while receiving treatment or therapy of advanced , their average IQ of 53-45. PAH-deficient patients in the neonatal period begins when a good diet, then IQ is different from normal people, and the growth is completely unaffected. BH4-deficient patients also suggested to be added in the neonatal period began to accept the treatment of central nervous conduction precursor substances.Patients received dietary or drug treatment, requiring regular ISR growth and development, intellectual development, blood and other essential amino acids phenylalanine concentration to confirm whether diet or medication appropriate. If caught and treated early, you can avoid the complications of mental retardation.

PAH deficiency / classic phenylketonuria (food type)Treatment depends mainly on diet control, and strictly limit the intake of phenylalanine, therefore need under the direction of a physician or nutritionist, eating a small amount of baby milk formula or a general after the age of a low-protein diet, and with a special formula milk (milk without phenylalanine ) replenish amino acids necessary to maintain normal growth and physiological functions.
Need to last a lifetime diet, female patients of childbearing age should be more strictly controlled to avoid maternal phenylketonuria (maternal PKU), resulting in the generation born disabled children produce. Some cases can be helped by medication, a slight relaxation diet, has reached more humane treatment goals and better prognosis.
BH4 deficiency (medication type)Treatment includes giving BH4 (1-5 mg / kg / day), may need to be controlled with diet has achieved the desired concentration of phenylalanine in the blood and central nervous conduction pioneer supplementary substances, including L-dopa and 5-hydroxy tryptophan. For DHPR deficient patients required additional supplementary Folinic acid.

Prognosis:Precautions everyday lifeIf the value of the U.S. youth revolt of the patient, often different from many people wanting his peers, so give diet therapy and companions started eating the same food, the cause of many behavioral deviations, even if during this period some patients pregnancy, will produce very serious deformity children.So we need to help these suffering children, to understand and to give them timely encouragement and support to assist them survive; Because patients can eat extremely limited, and special milk tastes really hard to swallow. This disease has now developed a number of low-phenylalanine foods for patients with this disease, but few domestic manufacturers are willing to import these foods, because the patient is small and low profits, while the vast majority of families also can not afford these expensive costs, hope that these patients can take control of their diet, it is a bit reluctant.

Phenylketonuria

1934 Norway Dr.Folling in the urine of patients with familial mental retardation were found to have a special taste stale, and later learned that the substance is phenylketonuria (phenylpyruvic acid), which and urine sugar diabetes is irrelevant, in 1937 was officially named as PKU (phenylketonuria; PKU).

Pathogenesis: Shaped phenylketonuria (BH4 deficiency) is an autosomal recessive amino acid metabolic disorders. Phenylalanine (phenylalanine) is the body's essential amino acids, the main metabolic reactions of phenylalanine (PHE) by the enzyme phenylalanine hydroxylase (PAH), BH4 cofactor role of substances such as tyrosine hydroxylase (Tyrosine). Shaped Phenylketonuria is necessary because PAH hydroxylation BH4 cofactor (Tetrahydrobiopterin) metabolic process occurs machine fails, the supply can not produce enough BH4 PAH use, resulting in phenylalanine can not be successfully converted into tyrosine, and in vivo large accumulation, and produce many toxic metabolites. In normal circumstances, BH4 is GTP through a series of reactions, including the GTP-Cyclohydrolase and 6-Pyruvoyltetrahydropterin Synthase (6PTS) the action of enzymes such as synthetic. Participation in phenylalanine hydroxylation reaction after hydrolysis by Dihydropteridine Reductase DHPR must restore BH4 form a network loop applications. BH4 only involved in phenylalanine into tyrosine hydroxylase, is also involved in tyrosine and tryptophan hydroxylation into Dopa (Tryptophan) into the 5-OH Tryptophan hydroxylation reaction. Where Dopa and 5-OH Tryptophan central nervous neurotransmitters Dopamine and Serotonin pioneer substances. Therefore, if the lack of BH4 cofactor, then the three reactions are blocked, this time there will be not only the symptoms of high phenylalanine, but also because of the lack of central nervous system neurotransmitters, and the emergence of many neurological symptoms. Now known to have the following five different enzyme deficiency causes phenylketonuria metabolic mechanisms:1 enzyme phenylalanine hydroxylase (PAH)2 guanine nucleoside triphosphate cyclization hydrolase (GTPCHI)3 propanedione tetrahydro neopterin synthase (PTPS)4 dihydrotestosterone pteridine reductase (DHPR)5 neopterin methanolamine dehydration enzyme (PCD)

Domestic common phenylketonuria There are three types as follows:1 phenylalanine hydroxylase (abbreviated PAH) lack of phenylketonuria:Phenylketonuria is mostly belong to this type, so called "classical PKU," such sick children at a low phenylalanine diet to treat, so called "therapeutic diet phenylketonuria."2 tetrahydro Health neopterin (referred BH4) deficiency type phenylketonuria coenzyme synthesis: Synthesis of BH4 deficiency may be known by three different enzyme deficiency caused by the domestic children with this type mostly 6-PTPS enzyme deficiency caused by BH4 synthesis deficiency. This type of domestic accounting for all PKU Phenylketonuria 20% to 30%. When this type of untreated phenylketonuria, often severe neurological symptoms (Example: pumping 'A'), the treatment is given to the first BH4 and nerve conduction chemotactic substance (Example: L - Dopa, 5 - HTP) and other drugs, thus It was commonly known as "drug therapy type phenylketonuria."3 dihydrotestosterone neopterin reductase (referred DHPR) deficiency phenylketonuria: BH4 metabolism DHPR play an important role, DHPR makes BH4 recycling are not scarce. BH4 deficiency causes DHPR not recycled, resulting in BH4 deficiency. Therefore, lack of DHPR "BH4-deficient synthesis of coenzyme phenylketonuria" in one type. Treatment is "diet" and "drugs" (Example: BH4 and nerve conduction first chemotactic substances) two-pronged approach, and added Folinic acid.


Clinical symptoms:
A lack of hydroxylation enzyme alanine (PAH): cause typical phenylketonuria. Show clinical symptoms of yellow hair, pale skin dryness and intelligent disability sequelae.
2, the lack of guanine nucleoside triphosphate cyclization hydrolase (Gtp cyclohydrolase I; GTPCHI), propanedione tetrahydro neopterin synthase (6-pyruvoyl tetrahydropterin synthase; PTPS), dihydrotestosterone pteridine reductase (dihydropteridine reductase; DHPR): the lack of any one of these three enzymes will cause BH4 deficiency. The clinical symptoms in addition to some of the typical symptoms of phenylketonuria, there are serious neurological symptoms (such as convulsions), growth retardation, easy to infection.
3, chronic congenital hemolytic anemia deficiency: although also cause BH4 deficiency, but clinical symptoms are mild, you may not need treatment. China's PKU patients about 20% to 30% of the students neopterin tetrahydro-deficient, and results to differ materially Western countries, the differential diagnosis of special needs in order to take proper treatment.



Diagnosis:PKU identified projects should include:1, the acceptance of the pediatrician with specialist training clinical assessment.2, blood amino acid analysis.3, the urine organic acid analysis by gas chromatography mass spectrometry (GC / Mass)4, urine by high performance liquid chromatography (HPLC) quantitative neopterin (neopterin; N) and biopterin (biopterin; B) the content, and calculate the percentage share of raw neopterin B% = [B / (B + N)] × 100%.5, erythrocyte DHPR activity quantification.6, BH4 oral loading test (BH4 loading test): the concentration of phenylalanine in the blood oral BH4 (7.5 mg / kg) 4-6 hours, the reduced 2mg/dl Hereinafter, taking the case of BH4 react ( responsive); phenylalanine completely reduced if the phenomenon, that means taking the case on BH4 no response (nonresponsive).



Differential diagnosis of PKUVia the above assessment and inspection, if elevated blood phenylalanine, tyrosine, but normal or low, and urine ketones abnormal metabolites styrene, it can be inferred for the PKU patients. And further to identify what type of case as phenylketonuria. Identification method is as follows:

1, a typical PKU: B% normal (or high), BH4 oral loading test no reaction, DHPR activity is normal.2, GTPCHI deficient PKU: B% normal, but the content is very low N and B, BH4 oral loading test responders, DHPR activity is normal.3, PTPS or SR-deficient PKU: B% <5 activity="" bh4="" br="" dhpr="" is="" loading="" normal.="" oral="" responders="" test="">4, DHPR deficient PKU: B%> 80%, BH4 loading test oral part of the reaction, DHPR activity is very low.5, PCD-deficient PKU: HPLC chromatogram in the urine, there are a lot of 7 - Biopterin (7-biopterin) substances.

Various types of treatment for PKU patients is as follows:1, a typical PKU: given a low phenylalanine diet control, so that the blood phenylalanine levels maintained at 4-8mg/dl, but also consider the protein, calories and other nutritional balance, in order to maintain the patient's normal growth. Diet as long as possible, to maintain at least six years old. Women continue to be the case even after childbearing age to avoid future occurrence of maternal phenylketonuria (maternal PKU), resulting in the generation born disabled children produce.2, auxiliary tetrahydro born neopterin synthesis deficient (guanine nucleoside triphosphate hydrolase cyclization, propanedione tetrahydro neopterin synthetase): to give BH4 (1-5 mg / kg / day), so that the blood The amphetamine acid content of at least maintained at 4mg/dL less. Because patients have neurological symptoms, should add a pioneer in the central nervous conduction material, L-dopa (5-15 mg / kg / day) and 5-hydroxy tryptophan (4-10 mg / kg / day), carbidopa (1-2mg / kg / day), nerve conduction drugs should add up to a small dose slowly, in order to achieve the maximum tolerable amount of patients.
3, hydrochlorothiazide pteridine reductase deficiency type: diet control, such as a "typical phenylketonuria", BH4 and central nervous conduction pioneer supplemental materials such as "secondary raw neopterin synthesis of tetrahydro-deficient," and added folinic acid.


Talk so much, but being a pharmacist BH4 looks do you recognize?
BH4: Tetrahydrobiopterin
He has two, one is 10mg, the other one is 50mg
BH4
Special reminder, this drug is to ice Oh, and -20 degrees, otherwise it will lose activity.

Wednesday, March 11, 2009

Phenylketonuria

First, PKU causes and symptoms

Dr.Folling Norway in 1934 at familial mental retardation found in the urine of patients with special triteness Taste
, Was later learned the substances are phenylketonuria (phenylpyruvic acid), officially named in 1937 for the benzene
Ketone urine disease (phenylketonuria; PKU). Phenylketonuria is an autosomal recessive genetic diseases, the main
If the body because of phenylalanine (phenylalanine; Phe) hydroxylation (hydroxylation) into tyrosine (tyrosine
; Tyr) of the metabolic pathway machine caused by impaired innate metabolic disorders. Currently known to have five different fermentation
Lack of pigment would cause such a metabolic drive impaired; these include: phenylalanine hydroxylation enzyme (phenylalanine
hydroxylase; PAH), guanine nucleoside triphosphate cyclohydrolase enzyme hydrolysis (Gtp cyclohydrolase I;
GTPCHI), C dione tetrahydro biopterin synthase (6-pyruvoyl tetrahydropterin synthase;
PTPS), HD-acridine Dihydroartemisinin reductase (dihydropteridine reductase; DHPR) and methyl amine neopterin
Dehydration enzyme (pterin-4 -carbinolamine dehydratase; PCD). Different depending on the lack of will
Have different clinical symptoms and diagnostic methods, and its treatment methods are also different.

The first enzyme phenylalanine hydroxylation (PAH) can cause a lack of the most common typical phenylketonuria. Its clinical
Show symptoms of yellow hair, pale skin dry and intellectual disability sequelae. According to literature reports, the European
PKU patients with the United States about 98 ~ 99% for this type, its incidence is about one ten thousandth, but there is a lot of areas
And racial differences. Domestic screening results showed that 870,000 newborns, PKU incidence of approximately 34,000
Thousandth, of which only about 70 ~ 80% typical phenylketonuria patients.

The second to fourth result in the lack of hydroxylation of phenylalanine into tyrosine when necessary auxiliary enzymes tetrahydro Health
Biopterin (tetrahydrobiopterin; BH4) lack. Their clinical symptoms apart from the typical symptoms of phenylketonuria and some outside
, There are serious neurological symptoms (such as convulsions), growth retardation, easy infection.

Fifth, although the lack of enzymes may also result in ancillary tetrahydro Health neopterin deficiencies, but the clinical symptoms of mild, may
Do not need treatment. PKU patients in China, about 20% ~ 30% for lack of tetrahydro Health neopterin type, with the West Country
The results to differ materially, especially in the differential diagnosis necessary in order to adopt the correct method of treatment.

Second, treatment of phenylketonuria

To prevent the occurrence of sequelae of PKU, except to be the right remedy, and the sooner the better therapeutic effect. Root
According to foreign literature, the treatment of patients at one month, the average IQ of 95, one to two months before administration
Treatment of patients, with an average IQ of 85; and advanced medical treatment or treatment, the average IQ was 53-45.
According to the experience of domestic and foreign literature, BH4 treatment type lack of a good prognosis, especially neurological symptoms
Control and the growth and development, if that is during the neonatal period for treatment, their IQ can be reached normal subscript
Prospective.

PKU patients with various types of treatment are as follows:

(A) typical PKU: given the low phenylalanine diet control, so that the blood phenylalanine concentration maintained at 4-8
mg / dL, but we must also consider the protein, calories, such as balanced nutrition to maintain the patient's normal growth. Drink
Fresh control the longer the better, at least to maintain the six-year-old. Female cases of child-bearing age should be continued until after
In order to avoid future occurrence of maternal phenylketonuria (maternal PKU), congenital disabilities caused by the next generation of children
Generated.

(B) Health Des tetrahydro biopterin synthesis lack of type (guanine nucleoside triphosphate cyclohydrolase enzyme hydrolysis, C iv dione
Hydrogen neopterin synthesis enzyme): given BH4 (1-5 mg / kg / day), so that the blood phenylalanine concentration of at least dimension
Holders at the following 4mg/dL. Because patients have neurological symptoms, have to supplement the central nervous system conduction precursors
Quality, L-dopa (5-15 mg / kg / day) and 5-hydroxy tryptophan (4-10 mg / kg / day),
carbidopa (1-2mg/kg/day), nerve conduction drugs are advised to add low-dose slowly up to meet the disease
Risk tolerance of the largest volume.

(C) acridine Dihydroartemisinin HD lack of reductase type: diet control such as "typical phenylketonuria", BH4 and the hub of God
By conduction pioneer supplementary material such as "Des tetrahydro Health neopterin synthesis lack of type", adding folinic acid.

Three, phenylketonuria confirmation and differential diagnosis

PKU neonatal screening is to provide the best method for early diagnosis. The most effective screening methods are measured filter
Paper blood spot samples of amphetamine acid, when the concentration is higher than 2mg/dL blood should be further reviewed. Phenylpropanoid
Acid concentrations continued to rise if the phenomenon, that is, there should be recognition and differential diagnosis. This screening during the neonatal period
Type of amino acid metabolic disorder diseases, it should be noted whether the cases have sufficient intake of protein (breast-feeding 48
Hours or more), in order to avoid the emergence of false-negative.

PKU identified projects should include:

(1) receive specialist training there is a pediatrician clinical evaluation.

(B) Analysis of blood amino acids.

(C) of the urine organic acids by gas chromatography mass spectrometry (GC / Mass)

(D) in urine by high performance liquid chromatography (HPLC) quantitative neopterin (neopterin; N) and biopterin (biopterin;
B) the content, and calculate the percentage of Health neopterin ratio B% = [B / (B + N)] × 100%.

(V) erythrocyte DHPR activity quantitatively.

(Vi) BH4 oral loading test (BH4 loading test): the blood concentration of phenylalanine in the oral BH4
(7.5 mg / kg) 4-6 hours later, down to the following 2mg/dl that the case has taken on the reaction of BH4
(responsive); if no reduced phenylalanine phenomenon, namely, that cases of BH4 without the use of anti -
Should be (nonresponsive).

The differential diagnosis of PKU

Through the above assessment and testing, if blood phenylalanine increased, but normal or low tyrosine and
Ketones in urine has phenylpropanoid metabolite abnormalities can be inferred by reason of PKU patients. And further identification of
Case for what type of phenylketonuria. Methods of identification are as follows:

(A) typical PKU: B% of normal (or high), BH4 oral loading test without reaction, DHPR activity is
Regular.

(B) GTPCHI lack of type PKU: B% normal, but the content of N and B is very low, BH4 oral loading
Test reaction has, DHPR activity normal.

(C) PTPS or SR-type lack of PKU: B% <5%, BH4 oral loading test has reaction, DHPR live
Of normal.

(Iv) DHPR lack of type PKU: B%> 80%, BH4 oral loading test partial response, DHPR live
Is very low.

(E) PCD type lack of PKU: high-performance liquid chromatography in the urine, there are a large number of 7 - biopterin
(7-biopterin) material.

Recent information